Genomics

Oxford, United Kingdom · Founded 2014 · Privately Held (backing)

Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. Genomics is based in Oxford, United Kingdom and was founded in 2014. Its last known valuation is $162 million. It has raised $142 million.

Last price · $/share

—

Implied valuation

$161.6M

Total raised

$142.2M

Last round

—

How much has Genomics raised?

$142.2Macross 0 recorded rounds

Free account

More of Genomics with a free account

·The complete investor list: 16 names
·Watch Genomics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Genomics investors

16 investors are on record for Genomics, including F-Prime Capital, Eight Roads, Salica Investments and University of Oxford. By type, the record holds 4 venture capital firms and 2 hedge funds.

For fundraisers

Raising for a company like Genomics?

16 investors have backed Genomics.

See all 16 investors →

Frequently asked about Genomics

How much has Genomics raised?: Genomics has raised $142.2M in total across 0 recorded funding rounds.